132 related articles for article (PubMed ID: 19362836)
1. Antagonists of the human A(2A) receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides.
Gillespie RJ; Bamford SJ; Gaur S; Jordan AM; Lerpiniere J; Mansell HL; Stratton GC
Bioorg Med Chem Lett; 2009 May; 19(10):2664-7. PubMed ID: 19362836
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.
Gillespie RJ; Bamford SJ; Clay A; Gaur S; Haymes T; Jackson PS; Jordan AM; Klenke B; Leonardi S; Liu J; Mansell HL; Ng S; Saadi M; Simmonite H; Stratton GC; Todd RS; Williamson DS; Yule IA
Bioorg Med Chem; 2009 Sep; 17(18):6590-605. PubMed ID: 19695884
[TBL] [Abstract][Full Text] [Related]
3. Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Gillespie RJ; Bamford SJ; Botting R; Comer M; Denny S; Gaur S; Griffin M; Jordan AM; Knight AR; Lerpiniere J; Leonardi S; Lightowler S; McAteer S; Merrett A; Misra A; Padfield A; Reece M; Saadi M; Selwood DL; Stratton GC; Surry D; Todd R; Tong X; Ruston V; Upton R; Weiss SM
J Med Chem; 2009 Jan; 52(1):33-47. PubMed ID: 19072055
[TBL] [Abstract][Full Text] [Related]
4. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Giles PR; Jordan AM; Knight AR; Lawrence A; Lerpiniere J; Misra A; Pratt RM; Todd RS; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2920-3. PubMed ID: 18407496
[TBL] [Abstract][Full Text] [Related]
5. Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Shook BC; Rassnick S; Hall D; Rupert KC; Heintzelman GR; Hansen K; Chakravarty D; Bullington JL; Scannevin RH; Magliaro B; Westover L; Carroll K; Lampron L; Russell R; Branum S; Wells K; Damon S; Youells S; Li X; Osbourne M; Demarest K; Tang Y; Rhodes K; Jackson PF
Bioorg Med Chem Lett; 2010 May; 20(9):2864-7. PubMed ID: 20347304
[TBL] [Abstract][Full Text] [Related]
6. Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
Peng H; Kumaravel G; Yao G; Sha L; Wang J; Van Vlijmen H; Bohnert T; Huang C; Vu CB; Ensinger CL; Chang H; Engber TM; Whalley ET; Petter RC
J Med Chem; 2004 Dec; 47(25):6218-29. PubMed ID: 15566292
[TBL] [Abstract][Full Text] [Related]
7. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
Gillespie RJ; Adams DR; Bebbington D; Benwell K; Cliffe IA; Dawson CE; Dourish CT; Fletcher A; Gaur S; Giles PR; Jordan AM; Knight AR; Knutsen LJ; Lawrence A; Lerpiniere J; Misra A; Porter RH; Pratt RM; Shepherd R; Upton R; Ward SE; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2916-9. PubMed ID: 18406614
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Jordan AM; Knight AR; Lerpiniere J; Misra A; Pratt RM; Roffey J; Stratton GC; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2924-9. PubMed ID: 18411049
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists.
Shah U; Lankin CM; Boyle CD; Chackalamannil S; Greenlee WJ; Neustadt BR; Cohen-Williams ME; Higgins GA; Ng K; Varty GB; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4204-9. PubMed ID: 18558486
[TBL] [Abstract][Full Text] [Related]
10. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1.
Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Cohen-Williams ME; Varty GB; Tulshian DB
Bioorg Med Chem Lett; 2005 Aug; 15(16):3670-4. PubMed ID: 15978806
[TBL] [Abstract][Full Text] [Related]
11. Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
Shook BC; Rassnick S; Chakravarty D; Wallace N; Ault M; Crooke J; Barbay JK; Wang A; Leonard K; Powell MT; Alford V; Hall D; Rupert KC; Heintzelman GR; Hansen K; Bullington JL; Scannevin RH; Carroll K; Lampron L; Westover L; Russell R; Branum S; Wells K; Damon S; Youells S; Beauchamp D; Li X; Rhodes K; Jackson PF
Bioorg Med Chem Lett; 2010 May; 20(9):2868-71. PubMed ID: 20338760
[TBL] [Abstract][Full Text] [Related]
12. Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
Neustadt BR; Hao J; Lindo N; Greenlee WJ; Stamford AW; Tulshian D; Ongini E; Hunter J; Monopoli A; Bertorelli R; Foster C; Arik L; Lachowicz J; Ng K; Feng KI
Bioorg Med Chem Lett; 2007 Mar; 17(5):1376-80. PubMed ID: 17236762
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease.
Volpini R; Dal Ben D; Lambertucci C; Marucci G; Mishra RC; Ramadori AT; Klotz KN; Trincavelli ML; Martini C; Cristalli G
ChemMedChem; 2009 Jun; 4(6):1010-9. PubMed ID: 19343763
[TBL] [Abstract][Full Text] [Related]
14. 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
Kiselgof E; Tulshian DB; Arik L; Zhang H; Fawzi A
Bioorg Med Chem Lett; 2005 Apr; 15(8):2119-22. PubMed ID: 15808481
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists.
Luthra PM; Mishra CB; Jha PK; Barodia SK
Bioorg Med Chem Lett; 2010 Feb; 20(3):1214-8. PubMed ID: 20018509
[TBL] [Abstract][Full Text] [Related]
16. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2.
Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Higgins GA; Cohen-Williams ME; Varty GB; Tulshian DB
Bioorg Med Chem Lett; 2005 Aug; 15(16):3675-8. PubMed ID: 15982882
[TBL] [Abstract][Full Text] [Related]
17. Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
Richardson CM; Gillespie RJ; Williamson DS; Jordan AM; Fink A; Knight AR; Sellwood DM; Misra A
Bioorg Med Chem Lett; 2006 Dec; 16(23):5993-7. PubMed ID: 16971117
[TBL] [Abstract][Full Text] [Related]
18. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
Shah U; Boyle CD; Chackalamannil S; Neustadt BR; Lindo N; Greenlee WJ; Foster C; Arik L; Zhai Y; Ng K; Wang S; Monopoli A; Lachowicz JE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4199-203. PubMed ID: 18562199
[TBL] [Abstract][Full Text] [Related]
19. Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.
Michielan L; Bolcato C; Federico S; Cacciari B; Bacilieri M; Klotz KN; Kachler S; Pastorin G; Cardin R; Sperduti A; Spalluto G; Moro S
Bioorg Med Chem; 2009 Jul; 17(14):5259-74. PubMed ID: 19501513
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists.
Dowling JE; Vessels JT; Haque S; Chang HX; van Vloten K; Kumaravel G; Engber T; Jin X; Phadke D; Wang J; Ayyub E; Petter RC
Bioorg Med Chem Lett; 2005 Nov; 15(21):4809-13. PubMed ID: 16153830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
